A carregar...

Chemoprevention of Prostate Cancer by D,L-Sulforaphane Is Augmented by Pharmacological Inhibition of Autophagy

There is preclinical evidence that oral administration of D,L-sulforaphane (SFN) can decrease the incidence or burden of early-stage prostate cancer (PIN) and well-differentiated cancer (WDC), but not late-stage poorly differentiated cancer (PDC). Because SFN treatment induces cytoprotective autopha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vyas, Avani R., Hahm, Eun-Ryeong, Arlotti, Julie A., Watkins, Simon, Stolz, Donna Beer, Desai, Dhimant, Amin, Shantu, Singh, Shivendra V.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3790864/
https://ncbi.nlm.nih.gov/pubmed/23921360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-0755
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!